Company: HCTI
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-027277
Chunk: 17

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 17
---
 in the previous paragraph.

<div align='center'>8</div>

The Purchase Warrants also
contain anti-dilution protection (subject to the floor price of $0.084) against Dilutive Issuances (as defined in the Purchase Warrants),
whereby the exercise price and the number of shares of Common Stock underlying the Purchase Warrants is subject to reset in the same manner
as described above.

The exercise price (subject
to the floor price of $0.084) and number of shares of Common Stock underlying the Purchase Warrants will also reset if there occurs any
share split, reverse share split, share dividend, share combination recapitalization or other similar transaction involving the Company’s
Common Stock (each, a “Share Combination Event”) and the lowest Weighted Average Price of the Common Stock during the period
commencing on the trading day immediately following the applicable Share Combination Event and ending on the fifth (5th) trading day immediately
following the applicable Share Combination Event Date is less than the Exercise Price then in effect in the same manner described above.

The Series B Warrants may
also be exercised at any time on an alternative cashless basis pursuant to which the number of shares issuable upon such alternative cashless
exercise of this Warrant shall equal the product of (i) the aggregate number of shares of Common Stock that would be issuable upon exercise
of the Series B Warrants if such exercise were by means of a cash exercise rather than a cashless exercise, multiplied by (ii) 3.0.

Pursuant to the Purchase Agreement,
the Company has agreed that until ninety (90) days after the effective date of the Registration Statement, neither the Company nor any
of its subsidiaries shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of
Common Stock or Common Stock equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case
other than as contemplated pursuant to the Registration Rights Agreement (as defined below) or, solely with respect to securities issued
pursuant to any share or option plan duly adopted for such purpose by the Company’s board of directors or a committee of non-employee
directors established for such purpose for services rendered to the Company, on Form S-8. However, the Company shall be permitted to issue
up to 500,000 options to purchase shares pursuant to the Company’s equity incentive plan, subject to certain exceptions set forth
in the